CHINESE PHARMA COMPANIES EYE INVESTMENTS IN SUB-SAHARAN AFRICA, BUT THE GOING IS TOUGH

China pharmaceutical industry investors want to help sub-Saharan African countries meet growing domestic demand for medicine in return for tax breaks and private-public partnership initiatives. But there are difficulties – including product quality and standards issues that impede the flow of Chinese Yuan into African pharma production. Indeed, converting financial resources into operating manufacturing plants can be a slow and troublesome process in the region’s less than optimal corporate governance climate. Nigeria, now Africa’s largest economy, with a ...


To view this content you need to be logged in. Please contact us to request access.